Abstract:Background5-Methylcytidine (m5C) methylation is an emerging epigenetic modification in recent years, which is associated with the development and progression of various cancers. However, the prognostic value of m5C regulatory genes and the correlation between m5C methylation and the tumor microenvironment (TME) in prostate cancer remain unknown. MethodsIn the current study, the genetic and transcriptional alterations and prognostic value of m5C regulatory genes were investigated in The Cancer Genome Atlas and Gene Expression Omnibus datasets. Then, an m5C prognostic model was established by LASSO Cox regression analysis. Gene set variation analyses (GSVA), gene set enrichment analysis (GSEA), clinical relevance, and TME analyses were conducted to explain the biological functions and quantify the TME scores between high-risk and low-risk subgroups. m5C regulatory gene clusters and m5C immune subtypes were identified using consensus unsupervised clustering analysis. The Cell-type Identification By Estimating Relative Subsets of RNA Transcripts algorithm was used to calculate the contents of immune cells. ResultsTET3 was upregulated at transcriptional levels in PCa compared with normal tissues, and a high TET3 expression was associated with poor prognosis. An m5C prognostic model consisting of 3 genes (NSUN2, TET3, and YBX1) was developed and a nomogram was constructed for improving the clinical applicability of the model. Functional analysis revealed the enrichment of pathways and the biological processes associated with RNA regulation and immune function. Significant differences were also found in the expression levels of m5C regulatory genes, TME scores, and immune cell infiltration levels between different risk subgroups. We identified two distinct m5C gene clusters and found their correlation with patient prognosis and immune cell infiltration characteristics. Naive B cells, CD8+ T cells, M1 macrophages and M2 macrophages were obtained and 2 m5C immune subtypes were identified. CTLA4, NSUN6, TET1, and TET3 were differentially expressed between immune subtypes. The expression of CTLA4 was found to be correlated with the degree of immune cell infiltration. ConclusionsOur comprehensive analysis of m5C regulatory genes in PCa demonstrated their potential roles in the prognosis, clinical features, and TME. These findings may improve our understanding of m5C regulatory genes in the tumor biology of PCa.

CMTM5 Exhibits Tumor Suppressor Activities and is Frequently Silenced by Methylation in Carcinoma Cell Lines

CMTM5 Exhibits Tumor Suppressor Activity Through Promoter Methylation in Oral Squamous Cell Carcinoma

Data from <i>CMTM3</i>, Located at the Critical Tumor Suppressor Locus 16q22.1, Is Silenced by CpG Methylation in Carcinomas and Inhibits Tumor Cell Growth through Inducing Apoptosis

Cmtm3, Located At The Critical Tumor Suppressor Locus 16q22.1, Is Silenced By Cpg Methylation In Carcinomas And Inhibits Tumor Cell Growth Through Inducing Apoptosis

Aberrant expression of CKLF-like MARVEL transmembrane member 5 (CMTM5) by promoter methylation in myeloid leukemia

CMTM5-v1 induces apoptosis in cervical carcinoma cells.

The Epigenetic Modifier PRDM5 Functions As a Tumor Suppressor Through Modulating WNT/β-catenin Signaling and is Frequently Silenced in Multiple Tumors.

Epigenetic identification of CHD5 as a critical 1p36.3 tumor suppressor frequently inactivated by promoter methylation in multiple carcinomas

CMTM5 is reduced in prostate cancer and inhibits cancer cell growth in vitro and in vivo

Cmtm5 Induces Apoptosis of Pancreatic Cancer Cells and Has Synergistic Effects with Tnf-Alpha

OPCML Gene Promoter Methylation and Gene Expression in Tumor and Stroma Cells of Invasive Cervical Carcinoma

CMTM5 is Downregulated and Suppresses Tumour Growth in Hepatocellular Carcinoma Through Regulating PI3K-AKT Signalling

Research advances in CKLF-like MARVEL transmembrane domain containing member 5]

CMTM3 Inhibits Human Testicular Cancer Cell Growth Through Inducing Cell-Cycle Arrest and Apoptosis

CMTM8 is Frequently Downregulated in Multiple Solid Tumors.

Comprehensive Analysis of M5c Methylation Regulatory Genes and Tumor Microenvironment in Prostate Cancer.

Bioinformatics-Based Discovery of CKLF-Like MARVEL Transmembrane Member 5 As a Novel Biomarker for Breast Cancer.

Reduced CMTM5 expression correlates with carcinogenesis in human epithelial ovarian cancer.

Re-Expression Of Lactotransferrin, A Candidate Tumor Suppressor Inactivated By Promoter Hypermethylation, Impairs The Malignance Of Oral Squamous Cell Carcinoma Cells.

CMTM3 Inhibits Cell Growth and Migration and Predicts Favorable Survival in Oral Squamous Cell Carcinoma

CMTM5-v1 inhibits cell proliferation and migration by downregulating oncogenic EGFR signaling in prostate cancer cells